Plant-Derived Flavonoids in Ocular Diseases: Redox Signaling, Neurovascular Protection, Regulated Cell Death, and Translational Frontiers
Flavonoids are compounds found in many plants and foods. Laboratory studies suggest that some can protect eye cells against oxidative and inflammatory injury, but these findings do not establish benefits for patients. This review examines which compounds were tested, how they act, whether they reach the eye, and how closely experimental models resemble human disease. It proposes a framework for identifying the evidence needed before selected flavonoids can be evaluated as complementary approaches to ocular care. Plant-derived flavonoids have been investigated as potential modulators of oxidative, inflammatory, and neurovascular injury in ocular diseases, but their clinical relevance remains uncertain. This narrative review critically examines the literature published from January 2016 to August 2026, supplemented by selected earlier landmark studies, to identify the evidence connecting experimental protection with plausible ocular interventions. The synthesis considers chemical identity, mechanistic support, ocular exposure, disease-model relevance, and functional outcomes. Experimental studies report modulation of antioxidant defenses, inflammatory signaling, mitochondrial homeostasis, cell survival, angiogenesis, and fibrotic remodeling. However, pathway-associated changes do not necessarily establish causal mechanisms, and protection in acute cellular or animal injury models does not establish efficacy in chronic human disease. Translation is further limited by metabolism, uncertain retinal exposure, heterogeneous preparations, and limited controlled clinical evidence. An author-proposed qualitative framework distinguishes the conclusions supported by individual findings from the additional validation required. Research priorities include standardized interventions, exposure-informed experiments, causal mechanistic studies, human-relevant models, and controlled trials with clinically meaningful outcomes. Flavonoids should therefore be regarded as candidates for further investigation as complementary interventions rather than established ocular therapeutics.
Authors
- Lidianys María Lewis Luján (ORCID: https://orcid.org/0000-0002-6548-3723)
- Rocío Sugich-Miranda (ORCID: https://orcid.org/0000-0002-6270-3487)
- Sergio Trujillo López (ORCID: https://orcid.org/0000-0002-6183-117X)
- Judas Tadeo Vargas-Durazo (ORCID: https://orcid.org/0000-0002-2034-1019)
- J.C. Galvez-Ruiz (ORCID: https://orcid.org/0000-0002-4035-313X)
- Simon Bernard Iloki Assanga (ORCID: https://orcid.org/0000-0002-2058-5881)
- Cinthia Jhovanna Pérez Martínez (ORCID: https://orcid.org/0000-0001-7138-5268)
- Diego Emmanuel Guerrero‐Magaña (ORCID: https://orcid.org/0009-0005-5040-9060)
- Sayil Alejandra De la Torre Othon (ORCID: https://orcid.org/0009-0009-2331-5586)
- Annette Pulcherie Iloki-Lewis (ORCID: https://orcid.org/0009-0002-2924-647X)
Institutions
- Universidad de Sonora (MX)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/ijms272210418
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00